REPREGEN
A spin-out from Imperial Innovations plc and headquartered within the Imperial College Incubator, RepRegen is poised to commercialize the initial product of its hard tissue repair and regeneration platform: StronBoneâ„¢ Bone Graft Substitute. The Company's hard tissue platform is based on 'smart' bioceramics designed to be used, initially, by orthopedic product manufacturers and surgeons. A major RepRegen materials science innovation is the use of Strontium, boosting the performance of the bioceramics.
REPREGEN
Industry:
Biopharma Biotechnology Health Care Manufacturing
Founded:
2006-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.repregen.com
Total Employee:
1+
Status:
Active
Contact:
44 20 7594 1326
Email Addresses:
[email protected]
Total Funding:
1.6 M USD
Technology used in webpage:
Nginx Baidu Analytics
Current Employees Featured
Founder
Investors List
Imperial Innovations
Imperial Innovations investment in Venture Round - RepRegen
Longbow Capital
Longbow Capital investment in Venture Round - RepRegen
Official Site Inspections
http://www.repregen.com
- Host name: ec2-3-140-13-188.us-east-2.compute.amazonaws.com
- IP address: 3.140.13.188
- Location: Columbus United States
- Latitude: 39.9653
- Longitude: -83.0235
- Metro Code: 535
- Timezone: America/New_York
- Postal: 43215
